Gangnam Severance Hospital
Parent institution Yonsei University Health System
Related institution Yonsei University
ROR: Yes
Works count: 8,272
Citations count: 131,700
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
2013 · Charles S. Fuchs, Jiří Tomášek, et al. · The Lancet
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · Yoon‐Koo Kang, Narikazu Boku, et al. · The Lancet
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
2017 · Norikazu Masuda, Soo-Jung Lee, et al. · New England Journal of Medicine